These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 30772387)

  • 41. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    Vicaire H; Pavec JL; Mercier O; Montani D; Boucly A; Roche A; Pradère P; Dauriat G; Feuillet S; Pichon J; Jevnikar M; Beurnier A; Jaïs X; Fadel E; Sitbon O; Humbert M; Savale L
    J Heart Lung Transplant; 2022 Sep; 41(9):1285-1293. PubMed ID: 35778258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk assessment in pulmonary arterial hypertension.
    Raina A; Humbert M
    Eur Respir Rev; 2016 Dec; 25(142):390-398. PubMed ID: 27903661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.
    Burger CD; Long PK; Shah MR; McGoon MD; Miller DP; Romero AJ; Benton WW; Safford RE
    Chest; 2014 Nov; 146(5):1263-1273. PubMed ID: 24901386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
    Yaylalı YT; Yağmur B; Sinan ÜY; Meriç M; Başarıcı İ; Kılıçkıran Avcı B; Şenol H; Nalbantgil S; Küçükoğlu S; Öngen Z
    Anatol J Cardiol; 2023 Aug; 27(8):479-485. PubMed ID: 37288853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.
    Benza RL; Farber HW; Frost A; Ghofrani HA; Gómez-Sánchez MA; Langleben D; Rosenkranz S; Busse D; Meier C; Nikkho S; Hoeper MM
    J Heart Lung Transplant; 2018 Apr; 37(4):513-519. PubMed ID: 29223470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk stratification in pulmonary arterial hypertension.
    Weatherald J; Boucly A; Sitbon O
    Curr Opin Pulm Med; 2018 Sep; 24(5):407-415. PubMed ID: 30004992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
    Kaemmerer H; Gorenflo M; Huscher D; Pittrow D; Apitz C; Baumgartner H; Berger F; Bruch L; Brunnemer E; Budts W; Claussen M; Coghlan G; Dähnert I; D'Alto M; Delcroix M; Distler O; Dittrich S; Dumitrescu D; Ewert R; Faehling M; Germund I; Ghofrani HA; Grohé C; Grossekreymborg K; Halank M; Hansmann G; Harzheim D; Nemes A; Havasi K; Held M; Hoeper MM; Hofbeck M; Hohenfrost-Schmidt W; Jurevičienė E; Gumbienè L; Kabitz HJ; Klose H; Köhler T; Konstantinides S; Köestenberger M; Kozlik-Feldmann R; Kramer HH; Kropf-Sanchen C; Lammers A; Lange T; Meyn P; Miera O; Milger-Kneidinger K; Neidenbach R; Neurohr C; Opitz C; Perings C; Remppis BA; Riemekasten G; Scelsi L; Scholtz W; Simkova I; Skowasch D; Skride A; Stähler G; Stiller B; Tsangaris I; Vizza CD; Vonk Noordegraaf A; Wilkens H; Wirtz H; Diller GP; Grünig E; Rosenkranz S
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32414075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry.
    Kaemmerer AS; Gorenflo M; Huscher D; Pittrow D; Ewert P; Pausch C; Delcroix M; Ghofrani HA; Hoeper MM; Kozlik-Feldmann R; Skride A; Stähler G; Vizza CD; Jureviciene E; Jancauskaite D; Gumbiene L; Ewert R; Dähnert I; Held M; Halank M; Skowasch D; Klose H; Wilkens H; Milger K; Jux C; Koestenberger M; Scelsi L; Brunnemer E; Hofbeck M; Ulrich S; Vonk Noordegraaf A; Lange TJ; Bruch L; Konstantinides S; Claussen M; Löffler-Ragg J; Wirtz H; Apitz C; Neidenbach R; Freilinger S; Nemes A; Opitz C; Grünig E; Rosenkranz S
    Cardiovasc Diagn Ther; 2021 Dec; 11(6):1255-1268. PubMed ID: 35070795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Farber HW; Miller DP; Poms AD; Badesch DB; Frost AE; Muros-Le Rouzic E; Romero AJ; Benton WW; Elliott CG; McGoon MD; Benza RL
    Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
    Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
    Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.
    Zelniker TA; Huscher D; Vonk-Noordegraaf A; Ewert R; Lange TJ; Klose H; Dumitrescu D; Halank M; Held M; Gall H; Pittrow D; Hoeper MM; Frankenstein L
    Clin Res Cardiol; 2018 Jun; 107(6):460-470. PubMed ID: 29368137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ
    Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
    Delcroix M; Staehler G; Gall H; Grünig E; Held M; Halank M; Klose H; Vonk-Noordegraaf A; Rosenkranz S; Pepke-Zaba J; Opitz CF; Gibbs JSR; Lange TJ; Tsangaris I; Huscher D; Pittrow D; Olsson KM; Hoeper MM
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
    Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
    JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Qu J; Li M; Zeng X; Zhang X; Wei W; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Zhang M; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y
    Front Med (Lausanne); 2021; 8():618486. PubMed ID: 33748158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
    Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
    Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
    Hoeper MM; Dwivedi K; Pausch C; Lewis RA; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Park DH; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Lange TJ; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Swift AJ; Thompson AAR; Elliot CA; Rosenkranz S; Condliffe R; Kiely DG; Halank M
    Lancet Respir Med; 2022 Oct; 10(10):937-948. PubMed ID: 35777416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters.
    Yogeswaran A; Tello K; Lund J; Klose H; Harbaum L; Sommer N; Oqueka T; Hennigs JK; Grimminger F; Seeger W; Ghofrani HA; Richter MJ; Gall H
    J Heart Lung Transplant; 2022 Mar; 41(3):400-410. PubMed ID: 34857454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.